Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant

Author(s):: Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.A.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S. (0000-0002-6700-188X); Roelen, D.L.; Claas, F.H.; Otten, H.G.

alloantibodyclinical researchpracticegraft survivalkidney failureinjurykidney transplantationnephrologyliving donor

Date issued: 2018-09-30
Language: English
Is part of: American Journal of Transplantation (2018), Vol. 18, no. 9, p. 2274-2284
hdl: 1887/86606
doi: 10.1111/ajt.14709
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175247/pdf/AJT-18-2274.pdf